Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women.

Antzeko izenburuak

• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. No cytogenetic data were reported.
  nork: Kingdom, J., et al.
  Argitaratua: (1997)
• Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
  nork: Rai, R., et al.
  Argitaratua: (1997)
• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
  nork: Piette, J. C., et al.
  Argitaratua: (1997)
• Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
  nork: Empson, Marianne B, et al.
  Argitaratua: (2005)
• Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage
  nork: Elmahashi, Mohamed O, et al.
  Argitaratua: (2014)